Continuous versus intermittent levofloxacin treatment in complicated urinary tract infections caused by urinary obstruction temporarily relieved by foreign body insertion

International Journal of Antimicrobial Agents

Volumn 28, Issue SUPPL. 1, 2006, Pages 82-85

  Tenke, Peter ^a   Kovacs, Bela ^a   Benkõ, Ria ^b   Ashaber, David ^a   Nagy, Elizabeth ^c  

^a Jahn Ferenc Del Pesti korhaz Budapest   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Antibiotic adsorption; Biofilm; Conditioning film; Continuous therapy; Intermittent therapy; Stent surface

Indexed keywords

LEVOFLOXACIN;

ADULT; ARTICLE; BIOFILM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ADSORPTION; FEMALE; FOREIGN BODY; HUMAN; MALE; PRIORITY JOURNAL; STENT; URINARY TRACT INFECTION; URINARY TRACT OBSTRUCTION;

ANTI-INFECTIVE AGENTS, URINARY; BIOFILMS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOREIGN BODIES; HUMANS; MALE; OFLOXACIN; STENTS; URETHRAL OBSTRUCTION; URINARY TRACT INFECTIONS;

EID: 33746740036     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.05.016     Document Type: Article

References (15)

1. Reid G., Tiezer C., Foerch R., Busscher H.J., Khoury A.E., and van der Mei H.C. The binding of urinary components and uropathogens to a silicone latex urethral catheter. Cell Mater 2 (1992) 253-260
2. Cormio L., Vuopio-Varkila J., Siitonen A., Talja M., and Ruutu M. Bacterial adhesion and biofilm formation on various double J stents in vivo and in vitro. Scand J Nephrol 30 (1996) 19-24
3. Tenke P., Jackel M., and Nagy E. Prevention and treatment of catheter-associated infections: myth or reality?. EAU Update Series 2/3 (2004) 106-115
4. Tenke P., Riedl C.R., Jones G.L., Williams G.J., Stickler D., and Nagy E. Bacterial biofilm formation on urologic devices and heparin-coating as preventive strategy. Int J Antimicrob Agents 23 Suppl. 1 (2004) S67-S74
5. Brown M.R.W., Collier P.J., and Gilbert P. Influence of growth rate on susceptibility to antimicrobial agents: modification of the cell envelope and batch and continuous culture studies. Antimicrob Agents Chemother 34 (1990) 1623-1628
6. Brown M.R., Allison D.G., and Gilbert P. Resistance of bacterial biofilms to antibiotics: a growth-related effect. J Antimicrob Chemother 22 (1988) 777-783
7. Reid G., Denstedt J.D., Kang Y.S., Lam D., and Naus C. Microbial adhesion and biofilm formation on ureteral stents in vitro and in vivo. J Urol 148 (1992) 1592-1594
8. Wollin T.A., Tieszer C., Riddell J.V., Denstedt J.D., and Reid G. Antibiotic resistance of Pseudomonas aeruginosa colonizing a urinary catheter in vitro. Eur J Clin Microbiol 4 (1985) 213-218
9. Wollin T.A., Tieszer C., Riddell J.V., Denstedt J.D., and Reid G. Bacterial biofilm formation, encrustation and antibiotic adsorbtion to ureteral stents indwelling in humans. J Endourol 12 (1998) 101-111
10. Reid G., Habash M., Vachon D., Denstedt J., Riddell J., and Beheshti M. Oral fluoroquinolone therapy results in drug adsorption on ureteral stents and prevention of biofilm formation. Int J Antimicrob Agents 17 (2001) 317-320
11. Liang H., Kays M.B., and Sowinski K.M. Separation of levofloxacin, ciprofloxacin, gatifloxacin, moxifloxacin, trovafloxacin and cinoxacin by high-performance liquid chromatography: application to levofloxacin determination in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 772 (2002) 53-63
12. Reid G., Davidson R., and Densterd J.D. XPS, SEM and EDX analysis of conditioning film deposition onto ureteral stents. Surf Interf Analy 21 (1994) 581-586
13. Reid G., Potter P., Dalenay G., Hsieh J., Nicoshia S., and Hayes K. Ofloxacin for treatment of urinary tract infections and biofilms in spinal cord injury. Int J Antimicrob Agents 4 (2000) 305-307
14. Nickel J.C., and Downey J. Movement of Pseudomonas aeruginosa along catheter surfaces. A mechanism in pathogenesis of catheter-associated infection. Urology 39 (1992) 93-98
15. Goto T., Nakame Y., Nishida M., and Oh Y. In vitro bactericidal activities of beta-lactamases, amikacin and fluoroquinolones against Pseudomonas aeruginosa biofilm in artificial urine. Urology 53 (1999) 1058-1062